Fisher Asset Management’s Sutro Biopharma STRO Stock Holding History

Fisher Asset Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$879K	Sell	35,295 -10	-0%	-$181	﹤0.01%	703
2025 Q4	$408K	Buy	35,305 +10	+0%	+$95	﹤0.01%	815
2025 Q3	$307K	Hold	35,295	–	–	﹤0.01%	890
2025 Q2	$252K	Hold	35,295	–	–	﹤0.01%	918
2025 Q1	$230K	Buy	35,295 +8,161	+30%	+$129K	﹤0.01%	946
2024 Q4	$499K	Hold	27,134	–	–	﹤0.01%	775
2024 Q3	$939K	Hold	27,134	–	–	﹤0.01%	668
2024 Q2	$795K	Buy	27,134 +7,482	+38%	+$296K	﹤0.01%	708
2024 Q1	$1.11M	Hold	19,652	–	–	﹤0.01%	673
2023 Q4	$843K	Hold	19,652	–	–	﹤0.01%	712
2023 Q3	$682K	Hold	19,652	–	–	﹤0.01%	802
2023 Q2	$914K	Buy	+19,652	New	+$978K	﹤0.01%	793

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fisher Asset Management's STRO Position: Q1 2026 in Review

Fisher Asset Management reduced its Sutro Biopharma (STRO) stake by 0.03% in Q1 2026, selling an estimated $181 and leaving 35,295 shares worth $879K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Fisher Asset Management first reported a position in STRO in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.11M in Q1 2024. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

Fisher Asset Management held 35,295 shares of Sutro Biopharma worth $879K as of Q1 2026.
Fisher Asset Management sold 10 Sutro Biopharma shares in Q1 2026, an estimated $181.
Sutro Biopharma made up ﹤0.01% of Fisher Asset Management's portfolio in Q1 2026, its #703 holding.
Fisher Asset Management first reported a position in Sutro Biopharma in Q2 2023 and has held it in 12 quarters since.
Fisher Asset Management's Sutro Biopharma position peaked at $1.11M in Q1 2024.
78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.